Moreover, there was also a study that reported that miR-144-5p increased the sensitivity of NSCLC to radiation therapy by targeting activating transcription factor 2 (ATF2), implying that miR-144-5p could be a biomarker for radiation therapy response 107. This evidence concerns the gene ATF2 and non-small cell lung carcinoma.